TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19874153

Group type: EXPERIMENTAL
Intervention: High-dose naltrexone (100 mg/d)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) without Contingency Management (CM)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Contingency Management (CM) added to CBT
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 16923926

Group type: EXPERIMENTAL
Intervention: Thyroxine treatment
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 196
Study: 15365066

Group type: EXPERIMENTAL
Intervention: Doxorubicin (60 mg/m2) plus cyclophosphamide (600 mg/m2) every 3 weeks for four cycles
Number of subjects: 1458
Study: 11176936

Group type: EXPERIMENTAL
Intervention: Urinary myelin basic protein-like material (MBPLM)
Number of subjects: 662
Study: 9135893

Group type: EXPERIMENTAL
Intervention: 17 Gy in two fractions (1 week apart)
Number of subjects: 216

Group type: COMPARATOR
Intervention: 22.5 Gy in five daily fractions
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 216
Study: 7962328

Group type: EXPERIMENTAL
Intervention: GH-deficient group (panhypopituitary patients)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 20
Study: 2958947

Group type: EXPERIMENTAL
Intervention: Aqueous procaine penicillin G (4.8 X 10(6) units im plus 1.0 g of oral probenicid)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Oral ampicillin (3.5 g plus 1.0 g of oral probenicid)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Spectinomycin (2.0 g im)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Oral rosoxacin (300 mg)
Number of subjects: 140
Study: 28479405

Group type: EXPERIMENTAL
Intervention: Gamified WM training (25 sessions)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Gamified WM training
Number of subjects: 91

Group type: COMPARATOR
Intervention: Sham training (control)
Number of subjects: 91
Study: 27260149

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 2 μg/kg (Group I)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Intranasal clonidine 3 μg/kg (Group II)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Intranasal saline 0.5 ml (Group III)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both dexmedetomidine and clonidine
Number of subjects: 105
Study: 24630881

Group type: EXPERIMENTAL
Intervention: Smoking (smokers)
Number of subjects: 13819
Study: 21614497

Group type: EXPERIMENTAL
Intervention: Perineal massage with Vaseline
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 19912160

Group type: COMPARATOR
Intervention: Control epidural (bupivacaine)
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Combined Spinal Epidural
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Low Dose Infusion
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Non-epidural
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Older age groups
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Non-white ethnicity
Number of subjects: 1054
Study: 18421802

Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion test (RTD)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 16409700

Group type: EXPERIMENTAL
Intervention: Support counselling by the embryologist
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine treatment, no counselling)
Number of subjects: 60
Study: 12559938

Group type: EXPERIMENTAL
Intervention: abciximab + primary PTCA
Number of subjects: 31

Group type: COMPARATOR
Intervention: primary PTCA alone
Number of subjects: 31
Study: 11151875

Group type: EXPERIMENTAL
Intervention: 600 mg oral erythromycin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8606267

Group type: EXPERIMENTAL
Intervention: 50,000 IU of urokinase (group A)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 500,000 IU of urokinase (group B)
Number of subjects: 98
Study: 1334539

Group type: COMPARATOR
Intervention: cisplatin (80 mg/m2, day 1)/etoposide (100 mg/m2, days 1, 3, 5) (PE)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: cisplatin (80 mg/m2, day 1)/etoposide (100 mg/m2, days 1, 3, 5)/ifosfamide (2 g/m2, days 1, 2, 3) (PEI)
Number of subjects: 92
Study: 6466532

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 10 micrograms kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine 20 micrograms kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (lower dose range of glycopyrrolate and atropine)
Number of subjects: 0
Study: 31382232

Group type: EXPERIMENTAL
Intervention: TUG test with picture condition under qualitative verbal instructions
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: TUG test with picture condition under nonqualitative verbal instructions
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: TUG test with qualitative verbal instructions
Number of subjects: 210

Group type: COMPARATOR
Intervention: TUG test with nonqualitative verbal instructions
Number of subjects: 210
Study: 28122609

Group type: COMPARATOR
Intervention: Standard telePRO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open access telePRO
Number of subjects: 0
Study: 25689725

Group type: EXPERIMENTAL
Intervention: Chronotherapeutic intervention (wake group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Exercise group
Number of subjects: 75
Study: 23547079

Group type: EXPERIMENTAL
Intervention: 90Y-ibritumomab
Number of subjects: 409

Group type: COMPARATOR
Intervention: Control
Number of subjects: 409
Study: 21696081

Group type: EXPERIMENTAL
Intervention: 0.5% isobaric racemic bupivacaine 3 mL
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 0.5% isobaric levobupivacaine 3 mL
Number of subjects: 70
Study: 18713312

Group type: EXPERIMENTAL
Intervention: Acid infusion (HCl 0.15 mol L(‐1))
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Acid infusion aspirated 3 cm distally
Number of subjects: 18
Study: 16710092

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.25 microg.kg(‐1) continuous infusion)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 62
Study: 12456442

Group type: EXPERIMENTAL
Intervention: Epidural morphine (0.6 mg) combined with epidural neostigmine (60 micro g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural neostigmine (60 micro g)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural morphine (0.6 mg)
Number of subjects: 60
Study: 10525786

Group type: EXPERIMENTAL
Intervention: CT scanning at 125 or 150 mAs
Number of subjects: 100

Group type: COMPARATOR
Intervention: CT scanning at 200 or 250 mAs
Number of subjects: 100
Study: 7793646

Group type: EXPERIMENTAL
Intervention: Dyck parameter set
Number of subjects: 30

Group type: COMPARATOR
Intervention: Marsh parameter set
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tackley parameter set
Number of subjects: 30
Study: 2024911

Group type: EXPERIMENTAL
Intervention: Enalapril/Hydrochlorothiazide (E/HCTZ: 20/12.5-40/25 mg)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Enalapril (E: 20-40 mg)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ: 12.5-25 mg)
Number of subjects: 146
Study: 7282909

Group type: EXPERIMENTAL
Intervention: Preventive antibiotic treatment with clindamycin and gentamycin
Number of subjects: 72

Group type: COMPARATOR
Intervention: No antibiotic therapy
Number of subjects: 72
Study: 6421007

Group type: EXPERIMENTAL
Intervention: ISDN (Isosorbide dinitrate) - mean dose 15.5 micrograms kg‐1 min‐1
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NTG (Nitroglycerin) - mean dose 5.5 micrograms kg‐1 min‐1
Number of subjects: 17
Study: 29924642

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg every 8 hours
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ibuprofen and Placebo
Number of subjects: 20
Study: 26414108

Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (TAPT) - aspirin plus clopidogrel plus cilostazol (100 mg loading, followed with 50 mg twice per day) for 3-6 months
Number of subjects: 127

Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (DAPT) - aspirin plus clopidogrel
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: TAPT
Number of subjects: 127

Group type: COMPARATOR
Intervention: DAPT
Number of subjects: 127
Study: 25536256

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplementation
Number of subjects: 44567

Group type: COMPARATOR
Intervention: Iron-folic acid supplementation
Number of subjects: 44567
Study: 22158330

Group type: EXPERIMENTAL
Intervention: Indacaterol treatment
Number of subjects: 648
Study: 20299481

Group type: EXPERIMENTAL
Intervention: Online diabetes self-management program
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Online diabetes self-management program with initial A1C >7%
Number of subjects: 761

Group type: COMPARATOR
Intervention: Usual-care control subjects
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Reinforcement (e-mail)
Number of subjects: 761
Study: 18545113

Group type: EXPERIMENTAL
Intervention: HBOC-201
Number of subjects: 688

Group type: COMPARATOR
Intervention: PRBC
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: HBOC-201 (HH)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: HBOC-201 (HR)
Number of subjects: 688
Study: 15849530

Group type: EXPERIMENTAL
Intervention: Nonblack race
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Being married
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Low SF‐36 mental health composite score
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: >=2 prior PID episodes
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 780

Group type: COMPARATOR
Intervention: Histologic endometritis or evidence of endometrial Neisseria gonorrhoeae or Chlamydia trachomatis infection
Number of subjects: 780
Study: 12693313

Group type: EXPERIMENTAL
Intervention: Targeted, intensified, multifactorial intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study: 10503808

Group type: EXPERIMENTAL
Intervention: Educational outreach visits by trained pharmacists delivering messages from four evidence-based clinical practice guidelines.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study: 8686820

Group type: EXPERIMENTAL
Intervention: Urinary bladder temperature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oesophageal temperature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulmonary artery temperature
Number of subjects: 0
Study: 1881728

Group type: EXPERIMENTAL
Intervention: Pediatric home care program (comprehensive biomedical and psychosocial care)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 6806218

Group type: EXPERIMENTAL
Intervention: 200 rad daily to total tumor doses of 6000-7000 rad in 6-7 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: 400 rad daily to a total of approximately 4400 rad in 2-3 weeks
Number of subjects: 64
Study: 31045501

Group type: EXPERIMENTAL
Intervention: Video-based, personalized webpage
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 99
Study: 30563042

Group type: EXPERIMENTAL
Intervention: Low concentration H2 O2 exposure (2 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High concentration H2 O2 exposure (2 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GOX treatments (low and high H2 O2 production rates)
Number of subjects: 0
Study: 27350372

Group type: EXPERIMENTAL
Intervention: Therapeutic Hypothermia (TH)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Strict Therapeutic Normothermia (STN)
Number of subjects: 138
Study: 25017345

Group type: EXPERIMENTAL
Intervention: Dietary and lifestyle intervention (individual face-to-face and telephone sessions)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Dietary and lifestyle intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Observational period (control)
Number of subjects: 110
Study: 22460367

Group type: EXPERIMENTAL
Intervention: Group vocal improvement program (7 weekly lectures on anatomy, vocal hygiene, and vocal exercises)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (maintained normal activities, no vocal improvement orientations)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Group vocal improvement program
Number of subjects: 37
Study: 19533238

Group type: EXPERIMENTAL
Intervention: Nurses without endoscopy assistance experience
Number of subjects: 30

Group type: COMPARATOR
Intervention: Residents
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nurses with endoscopy assistance experience
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (residents and nurses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All trainee groups
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Residents and nurses
Number of subjects: 30
Study: 18338474

Group type: EXPERIMENTAL
Intervention: 15‐methyl PGF2alpha (125 microg) intramuscularly at the time of delivery of the anterior shoulder
Number of subjects: 100

Group type: COMPARATOR
Intervention: Methylergometrine (0.2 mg) after delivery of placenta
Number of subjects: 100
Study: 15665147

Group type: COMPARATOR
Intervention: Solving a puzzle during exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not solving a puzzle during exercise
Number of subjects: 0
Study: 12357149

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Current plus ex-smokers
Number of subjects: 489
Study: 10193676

Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg three times a day)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg once a day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7479625

Group type: EXPERIMENTAL
Intervention: 2‐mg nicotine gum
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 56
Study: 2305995

Group type: EXPERIMENTAL
Intervention: TTFCA 60 mg tid (Group A)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: TTFCA 30 mg tid (Group B)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: TTFCA 60 mg tid (Group D, normal subjects)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: TTFCA (both doses in Groups A and B)
Number of subjects: 62
Study: 7000223

Group type: EXPERIMENTAL
Intervention: Intramuscular cephradine 1 g 6-hourly for 48 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30475762

Group type: EXPERIMENTAL
Intervention: Personalized multi-modal digital health intervention targeting physical activity, nutrition, mental health, and cognitive training
Number of subjects: 8500
Study: 28476133

Group type: EXPERIMENTAL
Intervention: Palatal brushing and standard oral and denture hygiene measures
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard oral and denture hygiene measures
Number of subjects: 52
Study: 25452069

Group type: EXPERIMENTAL
Intervention: Automated telephone continuing care program (ATIVR) for 4 months
Number of subjects: 158

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 158
Study: 23786948

Group type: EXPERIMENTAL
Intervention: Structured lipid emulsion as parenteral alimentation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Physically mixed medium and long‐chain fat emulsion as parenteral alimentation
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 21698168

Group type: EXPERIMENTAL
Intervention: HPV-positive women (non-white)
Number of subjects: 2842

Group type: EXPERIMENTAL
Intervention: HPV-positive women (non-smokers)
Number of subjects: 2842

Group type: COMPARATOR
Intervention: HPV-negative women (non-smokers)
Number of subjects: 2842

Group type: EXPERIMENTAL
Intervention: HPV-positive women (ex-smokers)
Number of subjects: 2842

Group type: COMPARATOR
Intervention: HPV-negative women (ex-smokers)
Number of subjects: 2842
Study: 19771403

Group type: EXPERIMENTAL
Intervention: 25U BoNT/A diluted in 2.5 ml sodium chloride solution (group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 25U BoNT/A diluted in 4 ml sodium chloride solution (group II)
Number of subjects: 40
Study: 16532913

Group type: EXPERIMENTAL
Intervention: Intermittent bolus epidural analgesia (bupivacaine + fentanyl)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (bupivacaine + fentanyl)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (bupivacaine)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Groups receiving fentanyl (both patient-controlled and intermittent bolus)
Number of subjects: 90
Study: 12770656

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with hyperbaric bupivacaine 1.5 mL 0.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local infiltration with a 50‐mL mixture containing 10 mL bupivacaine 0.5%, 10 mL prilocaine HCl 2%, and 30 mL isotonic solution with 1:200,000 epinephrine in combination with intravenous midazolam sedation
Number of subjects: 60
Study: 11204034

Group type: EXPERIMENTAL
Intervention: Spatial filters for multichannel EEG
Number of subjects: 3
Study: 8935302

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg, daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg, daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nadolol (80 mg, daily)
Number of subjects: 100
Study: 1585682

Group type: EXPERIMENTAL
Intervention: Isomalt chocolate
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Sorbitol chocolate
Number of subjects: 162

Group type: COMPARATOR
Intervention: No chocolate
Number of subjects: 162

Group type: COMPARATOR
Intervention: Sucrose chocolate
Number of subjects: 162
Study: 3156999

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 33
Study: 29606135

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution with 20 mL/kg over 60 min at start of ERCP, followed by 3 mL/kg/h for 8 h thereafter
Number of subjects: 826

Group type: COMPARATOR
Intervention: No fluids or normal saline with a maximum of 1.5 mL/kg/h and 3 L/24 h
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 826
Study: 26902403

Group type: EXPERIMENTAL
Intervention: Anti-resorptive (AR) combination of pomegranate fruit and grape seed extracts
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Bone formation (BF) combination of quercetin and licorice extracts
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Combination of all four plant extracts (AR plus BF)
Number of subjects: 3
Study: 25542635

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB) angioplasty
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-pressure balloon (HPB) angioplasty
Number of subjects: 40
Study: 23465517

Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Watchful Waiting (WW)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 347
Study: 21736705

Group type: EXPERIMENTAL
Intervention: Induction of labour
Number of subjects: 680

Group type: COMPARATOR
Intervention: Expectant monitoring
Number of subjects: 680
Study: 19663089

Group type: EXPERIMENTAL
Intervention: Acupuncture group (Acup.)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Prozac group (P.)
Number of subjects: 440
Study: 16675182

Group type: EXPERIMENTAL
Intervention: Sitting posture (hip-flexed)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Right hip-flexed left lateral position (L)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Left hip-flexed right lateral position (R)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Supine 30 degrees lateral tilt (control group)
Number of subjects: 93
Study: 15383854

Group type: EXPERIMENTAL
Intervention: Trisacryl gelatin microspheres (group A)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Polyvinyl alcohol particles (PVA) (group B)
Number of subjects: 49
Study: 10917328

Group type: EXPERIMENTAL
Intervention: Knowledge Examination (KE) and Mock Resuscitation (MR) at six months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Knowledge Examination (KE) only at six months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Mock Resuscitation (MR) only at six months
Number of subjects: 43

Group type: COMPARATOR
Intervention: No intermediate testing
Number of subjects: 43
Study: 9311050

Group type: EXPERIMENTAL
Intervention: 100 micrograms beclomethasone dipropionate (BDP) combined with 200 micrograms salbutamol (group BDP-S, n = 9)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 200 micrograms salbutamol (group S, n = 8)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (group P, n = 6)
Number of subjects: 29
Study: 7974371

Group type: EXPERIMENTAL
Intervention: Allograft patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autograft patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allograft and Autograft patients
Number of subjects: 0
Study: 2727646

Group type: EXPERIMENTAL
Intervention: Autotransfusion of mediastinal blood (n = 67)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (n = 68)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Autotransfusion group
Number of subjects: 135

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 135
Study: 8744

Group type: EXPERIMENTAL
Intervention: Physostigmine (intravenous administration)
Number of subjects: 3
Study: 30948503

Group type: EXPERIMENTAL
Intervention: Tangminling pill
Number of subjects: 767
Study: 28082454

Group type: EXPERIMENTAL
Intervention: Experimental group (head nurses received individual feedback)
Number of subjects: 445

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 445
Study: 25425710

Group type: EXPERIMENTAL
Intervention: Portable oxygen concentrator
Number of subjects: 25

Group type: COMPARATOR
Intervention: Combined system (fixed device with continuous-flow oxygen and portable device with pulse dispensation)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Combined system
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 25